semaglutide approval Wegovy approved to help teens with obesity lose weight New Weight Loss Medication Wegovy™

Cardiovascular-related indicators included the incidence of major adverse cardiovascular events (MACE), cardiac function indicators, and the progression of atherosclerotic lesions

Further research identified GLP-1 in L cells of mammalian gut mucosa and later, it was proved that GLP-1 enhances insulin secretion in response to nutrient ingestion (7, 10, 11)

However, muscle loss often results from rapid weight loss, regardless of the method

Research has found that approximately 40% of the weight lost from taking semaglutide comes from lean mass, including muscle

While compounded semaglutide may offer flexibility for patients who cannot tolerate standard formulations or require a different delivery method, it lacks the rigorous testing and quality control associated with commercially produced semaglutide